Depressive Symptoms, Neurocognitive Impairment, and Adherence to Highly Active Antiretroviral Therapy Among HIV-Infected Persons
- 1 September 2004
- journal article
- Published by Elsevier BV in Psychosomatics
- Vol. 45 (5), 394-402
- https://doi.org/10.1176/appi.psy.45.5.394
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Psychiatric Disorders and Drug Use Among Human Immunodeficiency Virus–Infected Adults in the United StatesArchives of General Psychiatry, 2001
- HIV-associated neurologic disease incidence changes:Neurology, 2001
- Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV InfectionAnnals of Internal Medicine, 2000
- HAART Is Neuroprophylactic in HIV-1 InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Depressive Symptoms Decline Among Persons on HIV Protease InhibitorsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Predictors of Self-Reported Adherence and Plasma HIV Concentrations in Patients on Multidrug Antiretroviral RegimensJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent populationAIDS, 2000
- Sociodemographic and psychological variables influencing adherence to antiretroviral therapyAIDS, 1999
- The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic responseAIDS, 1999
- Highly active antiretroviral treatment in HIV infectionAIDS, 1998